SXTP (60 Degrees Pharmaceuticals, Inc. Common Stock) Stock Analysis - Analyst Ratings

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) is a publicly traded Healthcare sector company. As of May 21, 2026, SXTP trades at $1.38 with a market cap of $3.80M and a P/E ratio of -0.12. SXTP moved -1.42% today. Year to date, SXTP is -28.86%; over the trailing twelve months it is -85.23%. Its 52-week range spans $1.29 to $49.80. Analyst consensus is buy with an average price target of $14.10. Rallies surfaces SXTP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SXTP?

2 analysts cover SXTP: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $14.10.

SXTP Key Metrics

Key financial metrics for SXTP
MetricValue
Price$1.38
Market Cap$3.80M
P/E Ratio-0.12
EPS$-11.73
Dividend Yield0.00%
52-Week High$49.80
52-Week Low$1.29
Volume1.47K
Avg Volume0
Revenue (TTM)$1.01M
Net Income$-7.37M
Gross Margin22.26%

SXTP Analyst Consensus

2 analysts cover SXTP: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.10.

Latest SXTP News

Recent SXTP Insider Trades

  • DOW GEOFFREY S bought 9.67K (~$7.76K) on Dec 15, 2025.
  • DOW GEOFFREY S bought 3.61K (~$3.32K) on Dec 11, 2025.
  • DOW GEOFFREY S bought 9.35K (~$8.89K) on Dec 10, 2025.

Common questions about SXTP

What do analysts rate SXTP?
2 analysts cover SXTP: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $14.10.
Does Rallies show SXTP price targets?
Yes. Rallies tracks SXTP analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SXTP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SXTP. It does not provide personalized investment advice.
SXTP

SXTP